Abatacept 250 mg Injection in India : A Breakthrough in Treating RA
Abatacept 250 mg injection is a breakthrough in treating rheumatoid arthritis, offering relief by targeting the immune system to reduce inflammation and joint damage. Available as Abatacept 250 mg in India, it provides an effective treatment option f
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
E N D
Presentation Transcript
(+91) 8750275027 contact@impomedhealthcare.com C-70, SECOND FLOOR OFFICE -A, DDA SHEDS, OKHLA INDUSTRIAL AREA, PHASE- 1, NEW DELHI-110020. Home Who We Are What We Do Diseases Treatment FAQs Contact Us ABATACEPT Home | Miscellaneous | Antivirals | ABATACEPT ABATACEPT Injection Description Composition Dosage Indications Contact Us ABATACEPT 250 MG INJECTION ORENCIA? (abatacept) is a soluble fusion protein that consists of the extracellular domain of human cytotoxic T- lymphocyte-associated antigen 4 (CTLA-4) linked to the modified Fc (hinge, CH2, and CH3 domains) portion of human immunoglobulin G1 (IgG1). Abatacept is produced by recombinant DNA technology in a mammalian cell expression system. The apparent molecular weight of abatacept is 92 kilodaltons. ORENCIA lyophilized powder for intravenous infusion is supplied as a sterile, white,preservative-free, lyophilized powder for intravenous administration. C-70, SECOND FLOOR OFFICE -A, DDA SHEDS, OKHLA INDUSTRIAL AREA, PHASE- 1, NEW DELHI-110020. +91-9007090388 +91-8750275027 contact@impomedhealthcare.com rahman@impomedhealthcare.com mohan.singh@impomendhealthcare.com Quick Links Diseases Corporate O?ce Home Who We Are What We Do Treatment FAQs Contact Us Blog Cancer Neurology Endocrinology Miscellaneous C-70, SECOND FLOOR OFFICE -A, DDA SHEDS, OKHLA INDUSTRIAL AREA, PHASE- 1, NEW DELHI-110020. , +91-8750275027 +91-9007090388 Established in New Delhi, India in 2020, ImpoMed Healthcare has grown over the years from a new start up to one of the Most Preferred Company for Facilitation of the USFDA/European FDA Approved. contact@impomedhealthcare.com rahman@impomedhealthcare.com Imported Drugs-Only mohan.singh@impomendhealthcare.com Follow us on: Copyright 2024 ImpoMed
